Menu Back toSession 8: Stakeholder Voice: Biosimilar Decision Making

Biosimilars Conference


Session 8: Stakeholder Voice: Biosimilar Decision Making

Session Chair(s)

Laura D. Wingate

Laura D. Wingate

  • Senior Vice President, Education, Support, and Advocacy
  • Crohn's & Colitis Foundation, United States
Using moderated case presentation learners will explore the decision-making process between a physician and their patient as they determine the best course of biologic/biosimilar treatment. The session will feature three treatment scenarios and discussion:
  • Shared decision-making process for a biologic naïve patient
  • Discussion between a patient and provider when deciding to switch from a innovator to a biosimilar
  • Discussion of the nocebo effect and its impact on decision making and switching behaviors
  • Dialogue around multi-switch data and real world experience in practice
The session will explore the education provided, questions asked by the patient, whether insurance or patient assistance programs factored in the decision and what additional information might have improved or better informed the decision process.
Learning Objective : At the conclusion of this session, participants should be able to:
  • Understand the factors that influence patient and provider decision as it relates to biosimilars
  • Articulate the barriers that are impacting the decision process between patient and provider
  • Comprehend the need for to offer biosimilar educational resource for both patients and providers

Speaker(s)

Francis  Farraye, MD, MS

speaker

Francis Farraye, MD, MS

  • Director, Inflammatory Bowel Disease Center, Professor of Medicine
  • Mayo Clinic Jacksonville, United States
Shubha  Bhat, PharmD, MS

Speaker

Shubha Bhat, PharmD, MS

  • Ambulatory Care Clinical Pharmacy Specialist - Gastroenterology
  • Boston Medical Center, Center for Digestive Disorders & Crohn's and Colitis, United States
Shaila  Abbott

Speaker

Shaila Abbott

  • Patient Advocate, United States
Alex  Hochstrasser

Speaker

Alex Hochstrasser

  • Patient Advocate
  • Ulcerative Colitis, United States